KL and Parkinson disease: The evidence that α-Klotho can decrease the inflammatory response comes from multiple sources and different approaches, such as overexpression of α-klotho in different animal models (AD, PD, etc.), direct administration in preclinic studies, and positive correlation in observational studies in humans.